drugset / Trial / NCT03610633

Oxytocin and Stress Response in Alcohol Use Disorder

NCT03610633 ↗

Phase 2 Completed 11 enrolled Medical University of South Carolina
RandomizedParallel-groupTriple-blindTreatment

Summary

Individuals with alcohol use disorder (AUD) will complete one functional Magnetic Resonance Imaging (fMRI) scanning visit. Prior to the scan, individuals will receive a nasal spray of either 24 international units (IU) of oxytocin (OT), or placebo (PBO). During the scan, they will perform the Montreal Imaging Stress Task (MIST), a social stress task. Subjective craving and anxiety data will be collected.

Timeline

Start
2016-03
Primary completion
2018-09
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 24 iu Intranasal

Indications